Skip to main content Skip to search Skip to main navigation

Insufficient traceability of the batch documentation

Excerpt from the GMP Compliance Adviser, Chapter 21.C.2.7

12 min. reading time | by Dr. Sabine Paris
Published in LOGFILE 11/2021

The deficiency

Time specifications for the start of production (preparation from 8:30) and for the end of production (15:30) were entered in the batch documentation.

However, microbiological monitoring in cleanroom Grade A during sterile production was only carried out between 11:00 and 15:00. It was not possible to determine from the batch documentation whether this covered the critical work steps.

In addition, the batch documentation could not sufficiently reconstruct the packaging material reconciliation, as the incoming package inserts were given in kg and the outgoing package inserts as number of pieces.

(Ref.: EU GMP Guide Part I No. 4.8 and 4.20)


That was the problem

For sterile production in cleanroom Grade A, microbiological monitoring is required during production. The monitoring should be carried out on a risk-based basis, especially during critical process steps (e.g. product is exposed to the ambient air for a "long" time). Annex 1 of the EU GMP Guide contains concrete requirements for this (see C.4.1 Annex 1 Manufacture of Sterile Medicinal Products).

The company had carried out a risk assessment and classified the process steps into "subject to monitoring" and "not subject to monitoring". However, the microbiological monitoring by means of sedimentation plate and active airborne microbial collection was only carried out over part of the complete process time. It was not apparent from the batch documentation that the critical process steps assessed as requiring monitoring had been carried out exclusively within this monitored time window between 11:00 and 15:00. Only the start and end of production were specified in the batch documentation, but these were both outside the monitored time window. This meant that it was not possible to verify whether all critical work steps were covered by microbiological monitoring. For the critical steps of aseptic production it could not be documented that the microbiological limit values had been complied with.


This is the most common pitfall

Batch documentation is a document that is very often in the hands of the employees carrying out the work and those with "inspection or review functions". The more often a process is performed, the more experience the employees have, but the more it becomes "routine". In everyday operation, not every specification or requirement can and will be questioned.

As a result, the traceability of the batch documentation is lost at one point or another. This is often particularly noticeable with regard to the points shown in Figure 1 and Figure 2:


Figure 1   Details of the chronological order, which are often not sufficiently traceable in the batch documentation

Figure 2   Reconciliation problems that complicate traceability


To avoid this error

The manufacturing instruction and the batch documentation are prepared at the latest at the start of process validation. After process validation, they are usually adjusted finally. Preparation and adaptation are also usually carried out with great care. Nevertheless, discrepancies or errors often remain.

Such discrepancies or errors in the batch documentation can usually only be detected by "independent" third parties, since the employees who work with it on a daily basis routinely "unwind" the "usual program".

In the audit, these persons should pay particular attention to the full traceability of individual steps. Traceability is particularly important

  • for points whose (chronological) order is relevant, and
  • between the batch documentation and supplementary printouts or documents of the batch documentation (instrument printouts, cleaning labels, particle monitoring, microbiological monitoring, temperature, humidity, differential pressures, etc.).

It is better to ask too much once, than too little once. Even if the production staff may not like it. It might have been noticed in the above described deficiency that although microbiological monitoring is carried out over a documented time window, a comparison with the time window of critical activities in the batch documentation is not possible.

Batch documentation must be traceable!

The history of a batch must be clearly traceable even after several years on the basis of the documentation.

This means that sometimes uncomfortable questions may be asked, e.g. by internal auditors – and the necessary (personnel) resources must be provided.

If individual steps are not traceable, e.g. with regard to the chronological order, it must be assessed whether they are GMP-relevant:

  • For example, is the duration of the encapsulation step GMP-relevant, because the capsules are thus exposed to the humid ambient air for a longer period of time and can therefore more or less stick together?
  • Can the information on the duration of the process interruption be waived, even if only a process interruption of 24 h was validated in the process validation?

Attention should also be paid to the consistency of different product-related documents with each other, especially process validation, validation of holding times, media fills or clean and dirty hold times with the information in the batch documentation.

The reconciliation in the course of the batch documentation is also often problematic. This is often due to the fact that different materials that are included in the reconciliation sheet are calculated in different units for incoming and outgoing materials or "pro forma data" is taken from delivery documents.

For example, incoming patient information leaflets often contain either a weight specification or the pro forma specification of the delivery note with e.g. 1000 leaflets. In fact, 1005 or even only 991 leaflets may have been delivered. On the output side, however, the used instructions for use are usually counted individually, so that an exact comparison is difficult. Here, an attempt should be made to align the units in a meaningful way. Information that is taken from delivery notes, for example, should be marked accordingly. This is not "correct" information that can be used for precise reconciliation.

If an "accurate" reconciliation cannot be drawn up, the associated risk should be assessed and measures taken if necessary.

To ensure the traceability of the batch documentation
  • Independent verification of traceability, e.g. in the context of self-inspections
  • Check of consistency with other documents, including process validation, validation of holding times, media fills, clean and dirty hold times
  • In particular, ensuring the traceability of the chronological order and reconciliation

Figure 3   Important measures for the traceability of batch documentation


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Dr. Sabine Paris
Dr. Sabine Paris

You may also be interested in the following articles:

Question of the Week | GMP-Verlag

What are the Benefits and Limitations of Passive Temperature-Controlled Containers for Drug Transport?

Here's the answer:
Read more
Outsourced Activities in the GDP Environment Part II: Contractual Agreements

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

When outsourcing GDP activities, there is a need for concrete delimitation of responsibilities between a client and a contractor. Read more about the goals and the contents of a quality agreement in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

Read more
FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

The FDA has updated its recommendations on Acceptable Intake (AI) limits for nitrosamine impurities. Under certain conditions, the Agency now accepts a Less-Than-Lifetime (LTL) adjustment of AI limits for medicinal products that are not intended for lifetime use. This also represents an alignment with the LTL concept of ICH M7(R2).
Read more
Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

As of 15 November 2026, active substances must be registered in the EMA's Substance Management Services (SMS) database before Swissmedic can include them in establishment licences and GMP certificates for active substance manufacturers. The new requirement results from modifications to the EudraGMDP database.
Read more
News: EMA

EMA: New Q&As for Biological Medicinal Products

The EMA has added a new section to its Q&As on biological medicinal products addressing medicinal products containing secretomes or extracellular vesicles (EVs) obtained from human or animal cells.
Read more
News: Europe

EU: Council Adopts the Pharmaceutical Package

On 28 September 2026, the Council of the European Union adopted the EU pharmaceutical package, marking another important step in the legislative process for the comprehensive reform of EU pharmaceutical legislation.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

With an named user licence, one user can access the knowledge portal; with a corporate licence, any number of users can access it.Approx. 5,000 pages of practical GMP knowledge with illustrations and forms: Practical guidance for rapid implementation in the workplaceDetailed descriptions of GMP-compliant systemsInternational laws and guidelines Always up-to-date thanks to regular updates Download Advantages and Prices60+ Sample Documents In addition, the GMP Compliance Adviser contains more than 60 sample documents (MS Office) and practical examples that you can use.Sample SOPsSample FormsSample ReportsSample DocumentationChecklistsProcess Diagrams (Flowcharts)Practical Examples of QRM Application (e.g., Risk Analyses)Sample Documents for Qualification and ValidationCase StudiesWritten by more than 80 authors with hands-on experience directly linked to the industryA team of over 80 experts interpret regulatory requirements and describe how they are implemented in practice.The authors are experienced in the pharmaceutical industry, consulting, and government agencies.

delivery immediately after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery immediately after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT